Photo of Glenn Grothman
R United States House · District 6 · Wisconsin On the 2026 ballot

Rep. Glenn Grothman

Compare
Total votes
2,837
all sessions
Attendance
99%
41 missed
Near the chamber average
With party
92%
of cast votes
Near the chamber average
Bipartisan score
4%
crosses aisle rarely
Near the chamber average
Sponsored
1,193
bills & resolutions
Near the chamber average
Committees
9
assignments
1,193 bills and resolutions

Sponsored bills

Total
1,193
Primary
104
Co-sponsor
1,089
This page
1,193
matching current filters
Co-sponsor HR 1761
In committee · United States House · Co-sponsor
Let Experienced Pilots Fly Act of 2023

Let Experienced Pilots Fly Act of 2023 This bill raises the mandatory retirement age for pilots engaged in commercial aviation operations from 65 to 67 years of age, unless the operation takes place in (1) the territorial airspace of a foreign county where such operations are prohibited by the foreign country, or (2) international airspace where such operations are not in compliance with the Annexes to the Convention on International Civil Aviation. The Federal Aviation Administration must also submit a report to Congress on further increasing the age limitation for pilots engaged in commercial aviation operations.

In committee Mar 24, 2023 1 co-sponsor
Co-sponsor HR 1628
In committee · United States House · Co-sponsor
CBD Product Safety and Standardization Act of 2023

CBD Product Safety and Standardization Act of 2023 This bill requires the Food and Drug Administration (FDA) to regulate food containing cannabidiol (CBD) derived from hemp as a food additive. (The FDA has determined that food containing added CBD cannot be sold in interstate commerce.) Under this bill, in order to be sold, a food containing CBD derived from hemp must conform with current FDA requirements pertaining to food additives or be generally recognized as safe (GRAS). (Under current law, a food additive with the GRAS designation is not subject to FDA premarket review and approval requirements.) In addition, such a food must comply with all other relevant FDA and labeling requirements. Such a food shall be exempt from an existing provision that prohibits the sale of a food containing an additive that is (1) an FDA-approved drug or biological product, or (2) subject to certain clinical investigations. The FDA must issue regulations pertaining to such foods that specify (1) the maximum amount of CBD derived from hemp per serving, (2) labeling and packaging requirements, and (3) any conditions for intended use.

In committee Mar 24, 2023 1 co-sponsor
Co-sponsor HR 1629
In committee · United States House · Co-sponsor
Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023

Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 This bill allows the use of hemp, cannabidiol (i.e., CBD) derived from hemp, or any other ingredient derived from hemp in a dietary supplement, provided that the supplement meets other applicable requirements. (Currently, the Food and Drug Administration's position is that CBD products may not be sold as dietary supplements.)

In committee Mar 24, 2023 1 co-sponsor
Co-sponsor HR 1608
In committee · United States House · Co-sponsor
Consumer and Fuel Retailer Choice Act of 2023

Maddy summaryThis bill amends the Clean Air Act to modify how the EPA handles waivers for ethanol in gasoline, specifically regarding "Reid Vapor Pressure" (a measure of fuel evaporation). It simplifies the process for fuel retailers to introduce certain ethanol blends into commerce by allowing them to meet vapor pressure standards through existing vehicle certification or approved waivers, rather than requiring new EPA approval for each blend. The key change removes barriers for retailers selling ethanol blends that comply with existing vehicle standards or approved waivers, directly affecting fuel manufacturers and retailers who must meet EPA fuel regulations. This is a technical regulatory adjustment focused on streamlining compliance, not creating new consumer benefits or programs.

In committee Mar 24, 2023 1 co-sponsor
Co-sponsor HCONRES 28
In committee · United States House · Co-sponsor
Expressing the sense of Congress that tax-exempt fraternal benefit societies have historically provided and continue to provide critical benefits to the people and communities of the United States.

Maddy summaryHCONRES 28 is a symbolic resolution expressing Congress's view that tax-exempt fraternal benefit societies - organizations providing life, health, and accident benefits to members - have long delivered critical community support. It states these societies, with about 7 million members nationwide, generate significant annual value through charitable work and volunteer activities (estimated at over $3.8 billion yearly). The resolution affirms that their tax-exempt status under Section 501(c)(8) of the tax code is essential for sustaining their volunteer-driven model and relieving pressure on government safety programs. As a non-binding expression of congressional sentiment, it does not alter existing laws or create new obligations.

In committee Mar 23, 2023 1 co-sponsor
Co-sponsor HJRES 30
Vetoed · United States House · Co-sponsor
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to "Prudence and Loyalty in Selecting Plan Investments and Exercising Shareholder Rights".

Maddy summaryH.J. Res. 30 seeks to block a Department of Labor rule that would have required retirement plan managers (like those handling 401(k)s) to follow strict "prudence and loyalty" standards when selecting investments and voting on company matters. The rule, published in December 2022, aimed to protect retirement savings by ensuring fiduciaries prioritize participants' interests. This resolution, if passed, would prevent the rule from taking effect, avoiding new compliance requirements for retirement plan managers and sponsors. It directly affects retirement plan administrators and the millions of participants in these plans.

Vetoed Mar 23, 2023 1 co-sponsor
Co-sponsor HR 1703
In committee · United States House · Co-sponsor
SECURE Flights Act

Maddy summaryHR 1703, the SECURE Flights Act, prohibits the use of specific immigration forms (like I-94 arrival records or I-200 warrants) as valid ID at airport security checkpoints. If such a document is presented, TSA must notify U.S. immigration and law enforcement agencies, and the individual may be barred from entering secure airport areas unless traveling for deportation or presenting a valid "covered ID" (e.g., passport, Global Entry card, or driver’s license). The bill also requires TSA to collect biometric data (like fingerprints or facial scans) from travelers who cannot verify U.S. citizenship and lack a covered ID, submitting this to the Homeland Security IDENT system. It directly affects travelers using non-standard immigration documents at airports, aiming to enhance security coordination between TSA and immigration authorities.

In committee Mar 22, 2023 1 co-sponsor
Co-sponsor HR 1551
In committee · United States House · Co-sponsor
Jobs and Opportunities for Medicaid Act

Maddy summaryHR 1551, the "Jobs and Opportunities for Medicaid Act," requires most Medicaid recipients aged 18-65 who are deemed "able-bodied adults" to work or volunteer at least 20 hours per week to maintain coverage, effective January 2024. It directly affects adults not excluded by specific categories (e.g., parents of young children, pregnant individuals, those with medical limitations, or in treatment programs). The bill amends Medicaid law to deny coverage for months when these individuals fail to meet the 20-hour weekly work or volunteer requirement. Key provisions define "able-bodied adult" and establish the specific work/volunteer threshold. This creates a new eligibility condition for Medicaid, not a funding or program expansion.

In committee Mar 17, 2023 1 co-sponsor
Co-sponsor HR 1462
In committee · United States House · Co-sponsor
DAIRY PRIDE Act

Maddy summaryThe DAIRY PRIDE Act would require food products using dairy-related terms (like "milk," "yogurt," or "cheese") to meet the FDA's definition of dairy - derived from animal milk - to prevent misleading labeling of plant-based alternatives. It directly affects producers of plant-based products currently marketed with dairy terms, such as almond or oat milk, which often lack comparable nutrition. The bill mandates the FDA issue enforcement guidance within 180 days and report to Congress on actions taken after two years. This policy change aims to align product names with the FDA's existing definition of dairy products under federal law.

In committee Mar 17, 2023 1 co-sponsor
Co-sponsor HR 1466
In committee · United States House · Co-sponsor
Safe RESEARCH Act

Safe Responsible Ethical Scientific Endeavors Assuring Research for Compassionate Healthcare Act or the Safe RESEARCH Act This bill prohibits the National Institutes of Health (NIH) from conducting or supporting research on human fetal tissue obtained from an abortion procedure. It also imposes other restrictions on human fetal tissue research. Under the bill, the NIH may conduct or support research on human fetal tissue only if it was obtained from a stillbirth. Current law allows research on tissue from stillbirths or from spontaneous or induced abortions. The bill also applies informed consent and other requirements applicable to research on the transplantation of human fetal tissue for therapeutic purposes to all research with human fetal tissue. This includes research on stem cells and other human fetal tissue alternatives. Additionally, human fetal tissue used for this research must be obtained in accordance with state anatomical gift laws. These laws govern organ and tissue donation for therapeutic, research, and other purposes. Some states already apply anatomical gift laws to human fetal tissue donation. Currently, executive branch officials may not prohibit the NIH from conducting or supporting research on the transplantation of human fetal tissue for therapeutic purposes. The bill repeals this limitation on executive branch officials. It also repeals a requirement that the NIH fund certain proposals for this research.

In committee Mar 17, 2023 1 co-sponsor
Showing 651 to 660 of 1,193 bills
Previous 1 … 65 66 67 … 120 Next